Adjusting for centre heterogeneity in multicentre clinical trials with a time‒to‒event outcome

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pharmaceutical statistics

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pst.1612PMID 24523155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modeling Survival Data Extending The Cox Model

  2016cited by this paper
• Software for semiparametric shared gamma and log-normal frailty models: An overview

  2012cited by this paper
• parfm: Parametric Frailty Models in R

  2012cited by this paper
• Frailty Model

  2011cited by this paper
• Comparison of different estimation procedures for proportional hazards model with random effects

  2007cited by this paper
• The design of simulation studies in medical statistics

  2006cited by this paper
• Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial

  2006cited by this paper
• Understanding Heterogeneity in Generalized Mixed and Frailty Models

  2005cited by this paper
• Modelling clustered survival data from multicentre clinical trials

  2004cited by this paper
• Modelling Survival Data in Medical Research

  2004cited by this paper
• Analysis of Multivariate Survival Data

  2002cited by this paper
• Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854.

  2001cited by this paper
• Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests.

  1999cited by this paper
• Should we adjust for covariates in nonlinear regression analyses of randomized trials?

  1998cited by this paper
• Frailty Models in Survival Analysis

  1996cited by this paper
• Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.

  1996cited by this paper
• Understanding Cox's regression model: a martingale approach : (preprint)

  1984cited by this paper

• Penalized Likelihood Optimization for Adaptive Neighborhood Clustering in Time-to-Event Data with Group-Level Heterogeneity

  2026cites this paper
• The impact of the number and the size of clusters on prediction performance of the stratified and the conditional shared gamma frailty Cox proportional hazards models

  2025cites this paper
• Hypothermic oxygenated perfusion (HOPE) against cancer recurrence after liver transplantation for hepatocellular carcinoma—study protocol for an international multicenter randomized controlled trial (HOPE4Cancer)

  2025cites this paper
• Exploring Mobile Phone Usage for Agricultural Inputs Access among Smallholder Farmers in Mpwapwa District, Tanzania: Demographic Factors, Access Methods, and Challenges

  2024cites this paper
• Correcting for heterogeneity and non‐comparability bias in multicenter clinical trials with a rescaled random‐effect excess hazard model

  2023cites this paper
• Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.

  2022cites this paper
• Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

  2022cites this paper
• Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine Hypertension

  2022cites this paper
• Comparison of Survival Among Adults With Rectal Cancer Who Have Undergone Laparoscopic vs Open Surgery

  2022cites this paper
• Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN)

  2021cites this paper
• Detection of outlying centers and influence diagnostics for the analysis of multicenter clinical trials

  2021cites this paper
• Clinicopathological features and current treatment outcomes of neuroendocrine thymic tumours.

  2020cites this paper
• Individual participant data meta‐analysis of intervention studies with time‐to‐event outcomes: A review of the methodology and an applied example

  2019cites this paper
• A gene-diet interaction-based score predicts response to dietary fat in the Women's Health Initiative.

  2019cites this paper
• (WWARN) AS-AQ

  2019cites this paper
• Center Effects in Hospital Mortality of Critically Ill Patients With Hematologic Malignancies*

  2019cites this paper
• Investigating covariate-by-centre interaction in survival data

  2018cites this paper
• Marginal structural Cox model to estimate the causal effect of clinical mastitis on Québec dairy cow culling risk.

  2017cites this paper
• Estimation du bénéfice de survie à partir de méta-analyse sur données individuelles et évaluation économique.

  2016cites this paper
• Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis

  2016cites this paper
• The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data

  2015cites this paper
• The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola

  2015cites this paper
• Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs.

  2015influential citation
• The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria : a meta-analysis of individual patient data The WorldWide Antimalarial Resistance Network ( WWARN ) AS-AQ Study Group

  2015cites this paper
• Beyond the shared frailty model

  2014cites this paper
• References

  year unknowncites this paper